Richard Schilsky - 06 Sep 2022 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Director
Signature
/s/ Douglas E. Onsi as attorney-in-fact for Richard Schilsky
Issuer symbol
LPTX
Transactions as of
06 Sep 2022
Net transactions value
$0
Form type
4
Filing time
08 Sep 2022, 21:35:27 UTC
Previous filing
08 Sep 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 06 Sep 2022 Common Stock 100,000 $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of equal quarterly installments for 12 quarters, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date.